Lundbeck (LUN)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Dk 99.25
   
  • 52 Week High: Dk139.00
  • 52 Week Low: Dk90.50
  • Currency: Denmark Kroner
  • Shares Issued: 196.12m
  • Market Cap: Dk19,465m

Lundbeck Overview

Lundbeck develops pharmaceuticals for treating diseases of the central nervous system including depression, schizophrenia, Alzheimers, Parkinson's and sleep disorders. It is a research-based company.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover 3.3
Op Mrgn 22.7%
ROCE 65.4%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 7.4%
PBT 23.4%
EPS 22.9%
DPS 22.8%

Lundbeck Fundamentals

Year Ending Revenue (Dkm) Pre-tax (Dkm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-06 9,221.00 1,632.80 5.24Dk 29.7 n/a -26% 1.57 1.0%
31-Dec-07 10,984.90 2,561.50 8.63Dk n/a n/a +65% 2.56 0.0%
31-Dec-08 11,281.80 2,122.90 7.67Dk 14.3 n/a -11% 2.30 2.1%
31-Dec-09 13,747.00 2,666.00 10.24Dk n/a n/a +34% 3.07 0.0%
31-Dec-10 14,765.00 3,289.00 12.58Dk n/a n/a +23% 3.77 0.0%

Lundbeck Forecasts

Lundbeck Forecasts data is not available for this company.

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Lundbeck Market Data

Currency Denmark Kroner
% Change -3.87 %
52 Week High Dk139.00
52 Week Low Dk90.50
Shares Issued 196.12m
Market Cap Dk19,465m

What The Brokers Say

Strong Buy 10
Buy 1
Neutral 4
Sell 1
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page